Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)
China flag China · Delayed Price · Currency is CNY
58.36
+1.45 (2.55%)
At close: Mar 27, 2026

SHE:300049 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,5951,3421,1471,001891.56
Other Revenue
-7.496.97.376.93
1,5951,3491,1541,009898.48
Revenue Growth (YoY)
18.26%16.93%14.37%12.27%11.26%
Cost of Revenue
399.36350.73291.39267.67239.14
Gross Profit
1,196998.28862.34741.09659.34
Selling, General & Admin
675.19584.24527.56474.49405.7
Research & Development
111.299.4982.4770.8264.79
Other Operating Expenses
10.238.0810.4310.7912.5
Operating Expenses
796.63711.59622562.68491.94
Operating Income
399.4286.69240.34178.41167.4
Interest Expense
--2.77-0.9-1.58-2.33
Interest & Investment Income
-16.0712.389.7310.54
Currency Exchange Gain (Loss)
-10.37-2.317.9316.48
Other Non Operating Income (Expenses)
-32.54-2.034.08-1.28-0.26
EBT Excluding Unusual Items
366.87308.34253.59193.21191.83
Impairment of Goodwill
--7.7---
Gain (Loss) on Sale of Investments
16.83-23.11---
Gain (Loss) on Sale of Assets
0.38-0.31-0.82-1.86-3.46
Asset Writedown
-33.52-0-4.71-0-
Other Unusual Items
--6.66-12.660.290.77
Pretax Income
350.56270.55235.4191.63189.14
Income Tax Expense
92.1474.6758.2946.2241.1
Earnings From Continuing Operations
258.42195.88177.11145.41148.04
Minority Interest in Earnings
-104.33-82.59-75.55-47.52-52.57
Net Income
154.09113.29101.5697.8995.47
Net Income to Common
154.09113.29101.5697.8995.47
Net Income Growth
36.02%11.54%3.75%2.54%54.22%
Shares Outstanding (Basic)
266264263263260
Shares Outstanding (Diluted)
266264263263260
Shares Change (YoY)
0.49%0.50%-0.01%1.30%1.31%
EPS (Basic)
0.580.430.390.370.37
EPS (Diluted)
0.580.430.390.370.37
EPS Growth
35.36%10.98%3.76%1.22%52.22%
Free Cash Flow
162.512.44115.6698.69142.94
Free Cash Flow Per Share
0.610.010.440.380.55
Dividend Per Share
---0.200-
Gross Margin
74.97%74.00%74.74%73.47%73.38%
Operating Margin
25.04%21.25%20.83%17.69%18.63%
Profit Margin
9.66%8.40%8.80%9.70%10.63%
Free Cash Flow Margin
10.19%0.18%10.03%9.78%15.91%
EBITDA
478.18358.88307.52236.39221.12
EBITDA Margin
29.97%26.60%26.65%23.43%24.61%
D&A For EBITDA
78.7872.1967.1857.9853.71
EBIT
399.4286.69240.34178.41167.4
EBIT Margin
25.04%21.25%20.83%17.69%18.63%
Effective Tax Rate
26.28%27.60%24.76%24.12%21.73%
Revenue as Reported
-1,3491,1541,009898.48
Advertising Expenses
-3.344.769.839.3
Source: S&P Global Market Intelligence. Standard template. Financial Sources.